SCHEMBL793113

SCHEMBL793113

C=C(C)C(=O)NCCCN1CCSCC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.44
RAB9A P51151 1/20 0.43
LMNA P02545 5/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TP53 P04637 2/20 0.43
TSHR P16473 1/20 0.40
POLB P06746 2/20 0.39
ALDH1A1 P00352 2/20 0.38
USP2 O75604 1/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7616877 0.90 NPC1 (0.46) KDM4ETSHRPOLBALDH1A1NPC1
SCHEMBL7620687 0.85 NPC1 (0.51) GAARAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL9635906 0.84 NPC1 (0.54) GAARAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL611220 0.81 GAA (0.68) GAARAB9ALMNAKDM4ETP53
SCHEMBL7607618 0.81 MEN1 (0.51) GAARAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL14559583 0.78 SMN1; SMN2 (0.45) GAALMNASMN1; SMN2TP53TSHR
SCHEMBL7615079 0.77 GAA (0.61) GAARAB9ALMNAKDM4ETP53
SCHEMBL7611652 0.77 MEN1 (0.50) GAARAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL15651389 0.77 GAA (0.49) GAARAB9ALMNAKDM4ESMN1; SMN2
SCHEMBL7614337 0.76 USP2 (0.46) GAARAB9AKDM4ESMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8753615-B2 Ethylene copolymer with PEG, cationic and anionic units, cosmetic composition including same and treatment method L'OREAL (FR) 2014-06-17 US disclosed
US-20120070399-A1 ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD L'OREAL (FR) 2012-03-22 US disclosed
WO-2010116063-A1 ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD L'OREAL (FR) 2010-10-14 WO disclosed
US-6423487-B2 ACYCLIC OR HETEROCYCLIC AMINOALKYL (METH)ACRYLAMIDE POLYMERS OR POLYMERS OF (METH)ACRYLATED ALKYLENE OXIDE ADDUCTS OF PIPERAZINES OR MORPHOLINE AS VISCOSITY ENHANCERS FUJI PHOTO FILM CO., LTD. (JP) 2002-07-23 US disclosed
US-20020015927-A1 Thermally processed image recording material FUJIFILM CORPORATION (JP) 2002-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070399-A1 ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD EGFR, ERCC1, ERCC5 GAA 451/4885RAB9A 3630/4885LMNA 2319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.